LIPOCINE INC. Prepaid Expense and Other Assets, Current
LIPOCINE INC. (LPCN) had Prepaid Expense and Other Assets, Current of $179.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-04
- 2026-06-30: Prepaid Expense and Other Assets, Current $179.00K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $285.06K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $787.60K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $683.80K.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $179.00K 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $285.06K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $787.60K 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $683.80K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $362.63K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $428.80K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $476.51K 10-K · filed 2026-03-10 | $567.91K 10-K · filed 2025-03-13 |
| 2024-09-30 | $588.82K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $297.05K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $583.09K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $773.42K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $594.10K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $690.90K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.13M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $945.32K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $1.23M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $603.55K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.38M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.51M 10-K · filed 2023-03-10 | |
| 2021-09-30 | $1.54M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $283.18K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $458.42K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $661.26K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $915.58K 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $147.31K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $373.37K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $545.89K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $754.50K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $148.93K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $411.41K 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $520.11K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $728.48K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $113.25K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $247.98K 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $408.23K 10-K · filed 2019-03-06 | |
| 2017-09-30 | $453.45K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $88.64K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $262.04K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $329.55K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $457.43K 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $154.03K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $268.86K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $350.16K 10-K · filed 2017-03-06 | |
| 2015-09-30 | $347.75K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $181.28K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $186.46K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $229.91K 10-K · filed 2016-03-10 | |
| 2014-09-30 | $285.92K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $1.27M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $256.39K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $770.03K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $251.75K 10-Q · filed 2013-11-13 | |
| 2012-12-31 | $90.93K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |